En klinisk relevant reduktion på 50% i biokemiske markører for knogleresorption blev observeret allerede en måned efter start på behandling med ibandronsyre 2, 5 mg.
A clinically meaningful reduction of 50% of biochemical markers of bone resorption was observed as early as one month after start of treatment with ibandronic acid 2.5 mg.